Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia
Mcog
1 other identifier
interventional
178
0 countries
N/A
Brief Summary
Many individuals with schizophrenia continue to hear voices, have false beliefs, and problems with attention, memory planning and everyday functioning even with medication treatment. The process of recovery in schizophrenia involves treating the whole person. This study will test a new Multimodal Cognitive Treatment (Mcog). Mcog works around problems in attention, memory and planning by using supports in the home such as signs, checklists, and alarms to improve everyday functioning. Mcog also helps the individual to examine the evidence for their beliefs and to deal with symptoms like voices that are not completely resolved with medications. We will compare 4 treatments to determine if this combined approach improves both symptoms and functioning for individuals with schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable schizophrenia
Started Apr 2008
Longer than P75 for not_applicable schizophrenia
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 26, 2013
CompletedFirst Posted
Study publicly available on registry
August 2, 2013
CompletedAugust 2, 2013
July 1, 2013
5.3 years
July 26, 2013
August 1, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Brief Psychiatric Rating Scale Psychosis Factor Score
Combines scores on BPRS for hallucinations, unusual thought content, suspiciousness and conceptual disorganization. Mean score varies from 1-7 with higher scores indicating more severe symptomatology
baseline to 9 months
Change in Multnomah Community Ability Scale
17-item scale assessing a variety of domains of community adjustment including Interference with functioning, Adjustment to living, Social competence, and Behavioral Problems. Higher scores reflect better community functioning.
Baseline to 9 months
Secondary Outcomes (2)
Change in Auditory Hallucination Rating Scale
Baseline to 9 months
Change in Delusion Rating Scale
Baseline to 9 months
Other Outcomes (1)
Change in Scale to Assess Unawareness of Mental Disorders
Baseline to 9 months
Study Arms (4)
Cognitive Behavior Therapy for Psychosis
EXPERIMENTALCognitive behavior therapy for psychosis is a manual-driven collaborative talk-therapy designed to help the individual identify appraisal biases and cognitive distortion, identify alternative explanations for events, and find ways to cope with the distress caused by persistent psychotic symptoms.
Cognitive Adaptation Training
EXPERIMENTALCAT is a manual driven treatment using environmental supports such as signs, alarms, checklists, electronic devices, and the organization of belongings to bypass cognitive and motivational impairments and to cue and sequence adaptive behavior.
Multi-modal Cognitive Therapy
EXPERIMENTALCombines Cognitive Behavior Therapy for Psychosis and Cognitive Adaptation Training into one home-delivered intervention
Treatment as Usual
ACTIVE COMPARATORMedication follow up and limited case management provided by the local community mental health center
Interventions
The CBT manual to be used for the present study was based upon the work of Kingdon and Turkington (2005) and Granholm et al., (2005) a group-delivered CBT skills training). Available manuals were modified to improve ease of training and to better accommodate the delivery of the full CBT treatment in the home environment. Supervision will be provided throughout the study by D. Turkington and S. Tai world renowned experts in CBT for psychosis. Training will be held for 1-2 weeks annually and supervision will proceed weekly via SKYPE. All therapists will be certified prior to providing treatment for the trial. Sessions are conducted weekly by master's and doctoral level therapists.
CAT supports are established and maintained on weekly home visits by bachelor's and master's level staff. Regular supervision will be provided by the PI who developed CAT.
A manual driven intervention combining CBT and CAT. Weekly sessions delivered in the home focus on altering cognitive biases using CBT and bypassing cognitive deficits using environmental supports
Eligibility Criteria
You may qualify if:
- Males and females who have given informed consent.
- Between the ages of 18 and 60.
- Diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV criteria as determined on the basis of the Structured Clinical Interview for Diagnosis Checklist (SCID-P) Checklist.
- Receiving treatment with an oral atypical antipsychotic medication other than clozapine
- Able to provide evidence of a stable living environment (individual apartment, family home, board and care facility) with no plans to move in the next year.
- Intact visual and auditory ability as determined by a computerized screening battery.
- Ability to read at the 5th grade level or higher based upon WRAT score.
- Able to understand and complete rating scales and neuropsychological testing.
- Delusions or hallucinations at a level of Moderate according to the BPRS. (Score of 4 or higher on items assessing hallucinations, unusual thought content, or suspiciousness.
You may not qualify if:
- History of significant head trauma, seizure disorder, or mental retardation.
- SOFAS scores \>70 indicating a high level of social and occupational functioning.
- Alcohol or drug abuse or dependence within the past 3 months.
- Currently being treated by an ACT team.
- History of violence in the past one year period.
- Exposure to CAT treatment in that past 2 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Director Division of Schizophrenia and Related Disorders
Study Record Dates
First Submitted
July 26, 2013
First Posted
August 2, 2013
Study Start
April 1, 2008
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
August 2, 2013
Record last verified: 2013-07